The comparative clinical characteristics of Astrakhan spotted fever and Crimean hemorrhagic fever in the Astrakhan Region


DOI: https://dx.doi.org/10.18565/epidem.2022.12.2.42-9

Ugleva S.V., Akimkin V.G., Ponezheva Zh.B., Vasilkova V.V., Shabalina S.V.

1) Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; 2) Astrakhan State Medical University, Ministry of Health of Russia, Astrakhan, Russia
Objective. To comparatively characterize two vector-borne infections: Astrakhan spotted fever (ASF) and Crimean hemorrhagic fever (CHF) in the Astrakhan Region.
Materials and methods. The incidence of ASF and CHF in 2000–2016 was analyzed. There were 3951 cases of ASF and 151 cases of CHF. The investigators used the data available in the primary accounting documents (Forms No. 058/y and No. 060/y) and in the schedules for epidemiological examination of the focus of an infectious disease (Registration Form No. 357/y) and results of epizootological surveys made in 11 districts of the Astrakhan Region, in the city of Astrakhan, and in the hospitals for the long-term monitoring of the foci.
Results. ASF and CHF were found to share common characteristics: the same transmission mechanisms, vectors, seasonality, and the similar disease onset. The main difference between ASF and CHF was in the severity of their course: if no severe cases of the disease were detected in ASF, severe CHF was observed in 30% of cases, while there was rather often hemorrhagic syndrome (up to 90%) and other serious complications.
Conclusion. The comparative clinical analysis of the course of two vector-borne infections (ASF and CHF) in the Astrakhan Region has shown that these infections share common characteristics: a vector-borne transmission route; infection of people who stay in the suburban areas and come into contact with ticks; spring and summer seasonality; and the onset of the disease. However, there are serious differences due to the fact that the CHF virus is more contagious and the disease is much more severe than ASF and is accompanied by massive internal bleeding and complications involving all organs and systems of the patient.

Literature


1. Онищенко Г.Г. Распространение вирусных природно-очаговых инфекций в Российской Федерации и меры по их профилактике. Эпидемиология и инфекционные болезни 2000; (4): 4–8.


Onishchenko G.G. [The spread of viral natural focal infections in the Russian Federation and measures for their prevention]. Epidemiоlоgy and infectious diseases 2000; (4): 4–8. (In Russ.).


2. Рудаков Н.В., Шпынов C.Н., Пеньевская Н.А., Транквилевский Д.В., Яцменко Е.В., Блох А.И. Эпидемиологическая ситуация по клещевым риккетсиозам в Российской Федерации в 2010–2019 гг. и прогноз на 2020 г. Проблемы особо опасных инфекций 2020; 1: 61–8. DOI: 10.21055/0370-1069-2021-1-73-80


Rudakov N.V., Shpynov S.N., Pen’evskaya N.A., Trankvilevskiy D.V. Yatsmenko E.V. Blokh A.I. [Features of the Epidemiological Situation on Tick-Borne Rickettsioses in the Russian Federation in 2010–2020 and Prognosis for 2021]. Problems of Particularly Dangerous Infections 2021; (1): 73–80. (In Russ.). DOI: 10.21055/0370-1069-2021-1-73-80


3. Лобан К.М., Лобзин Ю.В., Лукин Е.П. Риккетсиозы человека (руководство для врачей). М.: Элби, 2002. 473 c.


Loban K.M., Lobzin Yu.V., Lukin E.P. [Human rickettsiosis (a guide for physicians)]. Moscow: Elbi, 2002. 473 p. (In Russ.).


4. Углева С.В., Шабалина С.В. Риккетсиозы в регионе Нижнего Поволжья. Журнал микробиологии, эпидемиологии и иммунобиологии 2021; 98(2): 231–8. https://doi.org/10.36233/0372-9311-60


Ugleva S.V., Shabalina S.V. [Rickettsiosis in the Lower Volga Region]. Journal of microbiology, epidemiology and immunology 2021; 98(2): 231–8. (In Russ.). https://doi.org/10.36233/0372-9311-60


5. Ситников И.Г., Худоян З.Г., Алешковская Е.С. Риккетсиозы человека: учебное пособие. Ярославль: ЯГМУ, 2015. 65 c.


Sitnikov I.G., Khudoyan Z.G., Aleshkovskaya E.S. [Human rickettsiosis: a textbook]. Yaroslavl, 2015. 65 p. (In Russ.).


6. Углева С.В., Шабалина С.В., Покровский В.И. Итоги и перспективы изучения клещевых трансмиссивных лихорадок (на примере Астраханской риккетсиозной лихорадки). Инфекционные болезни 2016; 14(4): 5–10.


Ugleva S.V., Shabalina S.V., Pokrovskу V.I. [Results and prospects of the study of tick-borne fevers (on the example of Astrakhan rickettsial fever)]. Infectious diseases 2016; 14(4): 5–10. (In Russ.).


7. Покровский В.И., Углева С.В., Шабалина С.В. Сравнительная характеристика трансмиссивных лихорадок на территории Астраханской области (по данным клинико-эпидемиологических исследований). Терапевтический архив 2011; 83(11): 55–9.


Pokrovskу V.I., Ugleva S.V., Shabalina S.V. [Comparative characteristics of transmissible fevers in the Astrakhan region (according to clinical and epidemiological studies)]. Therapeutic archive 2011; 83(11): 55–9. (In Russ.).


8. Малеев В.В., Галимзянов Х.М., Бутенко А.М., Черенов И.В. Крымская геморрагическая лихорадка. Москва–Астрахань, 2003. 119 с.


Maleev V.V., Galimzyanov Kh.M., Butenko A.M., Cherenov I.V. [Crimean hemorrhagic fever]. Moscow–Astrakhan, 2003. 119 p. (In Russ.).


9. Покровский В.И., Касимова Н.Б., Галимзянов Х.М., Морозова Ю.В. Клинико-патогенетические и иммуногенетические особенности Астраханской риккетсиозной лихорадки. Астрахань, 2005. 91 с.


Pokrovskу V.I., Kasimova N.B., Galimzyanov Kh.M., Morozova Yu.V. [Clinical, pathogenetic and immunogenetic features of Astrakhan rickettsial fever]. Astrakhan, 2005. 91 p. (In Russ.).


10. Горелов А.В. Клиническое руководство по инфекционным болезням. М.: Медконгресс, 2020: 205–9.


Gorelov A.V. [Clinical guide to infectious diseases]. Moscow: Medkongress, 2020: 205–9. (In Russ.).


11. Тарасевич И.В. Астраханская пятнистая лихорадка. М.: Медицина, 2002. 171 с.


Tarasevich I.V. [Astrakhan spotted fever]. Moscow: Meditsina, 2002. 171 p. (In Russ.).


12. Черенов И.В., Галимзянов Х.М., Гольденберг А.А. Клинико-лабораторная характеристика тяжелых форм Крымской геморрагической лихорадки. Сб. научн. тр. «Природно-очаговые особо опасные инфекции на Юге России, их профилактика и лабораторная диагностика». Астрахань, 2001: 316–8.


Cherenov I.V., Galimzyanov Kh.M., Gol’denberg A.A. [Clinical and laboratory characteristics of severe forms of Crimean hemorrhagic fever. In: Collection of scientific works «Naturally focal especially dangerous infections in the South of Russia, their prevention and laboratory diagnostics»]. Astrakhan, 2001: 316–8. (In Russ.).


13. Онищенко Г.Г., Куличенко А.Н. (ред.). Крымская геморрагическая лихорадка. Воронеж: ООО «Фаворит», 2018. 288 с.


Onishchenko G.G., Kulichenko A.N. (eds.). [Crimean hemorrhagic fever]. Voronezh: Favorit, 2018. 288 p. (In Russ.).


14. Мирекина Е.В., Бедлинская Н.Р., Хаглышева Э.А. К вопросу о геморрагическом синдроме при Крымской геморрагической лихорадке. Новая наука: Проблемы и перспективы 2016; 10(2): 36–9.


Mirekina E.V., Bedlinskaya N.R., Khaglysheva E.A. [On the issue of hemorrhagic syndrome in Crimean hemorrhagic fever]. New Science: Problems and prospects 2016; 10(2): 36–9. (In Russ.).


15. Пахрутдинова Ж.М., Суктушинова С.Н., Бурлака У.И., Аквубука Ж.О., Идрисова М.Ш. Крымская геморрагическая лихорадка в Астраханской области: современные реалии эпидемиологии и клиники. Материалы всероссийского научного форума студентов с международным участием «Студенческая наука – 2020». Forcipe 2020; 3(3): 330–1. ISSN 2658-4174 eISSN 2658-4182


Pakhrutdinova Zh.M., Suktushinova S.N., Burlaka U.I., Akvubuka Zh.O., Idrisova M.Sh. [Crimean hemorrhagic fever in the Astrakhan region: modern realities of epidemiology and clinic. Abstracts Nationwide scientific forum of students 330 with international participation «Student science – 2020»]. Forcipe 2020; 3(3): 330–1. (In Russ.).


16. Bente D.A., Forrester N.L., Watts D.M., McAuley A.J., Whitehouse Ch.А., Bray M. [Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity]. Antiviral Res. 2013; 100(1): 159–89.


About the Autors


Svetlana V. Ugleva, MD, Associate Professor, Consultant, Organizational and Guidance department, Administrative and Managerial Subdivision, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; uglevas@bk.ru; https://orcid.org/0000-0002-1322-0155
Professor, Vasily G. Akimkin, MD, Academician of the Russian Academy of Sciences, Director, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; vgakimkin@yandex.ru; https://orcid.org/0000-0003-4228-9044
Zhanna B. Ponezheva, MD, Head, Clinical Department of Infectious Pathology, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; doktorim@mail.ru; https://orcid.org/0000-0002-6539-4878
Vera V. Vasilkova, Cand. Med. Sci., Head, Department of Infectious Diseases and Epidemiology, Astrakhan State Medical University, Ministry of Health of the Russian Federation, Astrakhan, Russia; vasilkova.ver@yandex.ru; https://orcid.org/0000-0002-7539-1910
Professor Svetlana V. Shabalina, MD, Leading Researcher, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; +7 (906) 743-48-64; svs2810@mail.ru; https://orcid.org/0000-0001-7102-5414


Similar Articles


Бионика Медиа